Targetoid-like Lesions in the Setting of Systemic Lupus Erythematosus: A Case of Rowell Syndrome

J Rheumatol. 2020 Feb;47(2):298-299. doi: 10.3899/jrheum.181021.

Authors

Jordan M Ward¹, Jaclyn N Hess², Loretta S Davis³

Affiliations

¹ Resident physician in Internal Medicine Residency Program at the Medical College of Georgia at Augusta University; joward@augusta.edu.
² Chief Resident in the Department of Dermatology at the Medical College of Georgia at Augusta University.
³ Chief of the Department of Dermatology and Residency Program Director at the Medical College of Georgia at Augusta University, Augusta, Georgia, USA.

PMID: 32007943
DOI: 10.3899/jrheum.181021

No abstract available

Publication types

Case Reports

MeSH terms

Adrenal Cortex Hormones / therapeutic use
Adult
Antirheumatic Agents / therapeutic use
Diagnosis, Differential
Erythema Multiforme / complications*
Erythema Multiforme / drug therapy
Female
Humans
Hydroxychloroquine / therapeutic use
Immunosuppressive Agents / therapeutic use
Lupus Erythematosus, Systemic / complications*
Lupus Erythematosus, Systemic / drug therapy
Methotrexate / therapeutic use
Raynaud Disease / complications*
Sjogren's Syndrome / complications*
Sjogren's Syndrome / drug therapy
Sunlight / adverse effects
Syndrome
Treatment Outcome

Substances

Adrenal Cortex Hormones
Antirheumatic Agents
Immunosuppressive Agents
Hydroxychloroquine
Methotrexate